Another T2D Drug CV Win; Arm Rehab Linked to Aphasia Recovery; HFpEF Biomarker
Medical Health News,
The GLP-1 receptor agonist dulaglutide (Trulicity) significantly reduced the primary composite endpoint of cardiovascular death…
The GLP-1 receptor agonist dulaglutide (Trulicity) significantly reduced the primary composite endpoint of cardiovascular death…
The GLP-1 receptor agonist dulaglutide (Trulicity) significantly reduced the primary composite endpoint of cardiovascular death…
New research published inFrontiers in Neurologyfinds that robotic arm rehabilitation in chronic stroke patients with aphasia…
In chronic stroke patients with aphasia, robotic arm rehabilitation was found to promote speech and language function recovery.